To answer HPLC_Greg's question specifically:

From a clinical standpoint, GLP-1 therapy in patients over is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

Want to share my personal experience related to GLP-1 therapy in patients over since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 251 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 18 months later: I am down 86 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The GLP-1 therapy in aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on GLP-1 therapy in patients.

To answer GraceAZ_72: my doctor and I discussed the options and went with brand.

Quick update: I have noticed more improvement since posting this. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Subscribing to this thread. GLP-1 therapy in patients is exactly what I've been researching. 🙏

Just wanted to say — for anyone reading this GLP-1 therapy in thread who is feeling discouraged: it gets better. The first month are the hardest. Hang in there. 💪